Haematological cancer
C66 – C71
- C66: Antibody-secreting heterohybridomas produced from cells of chronic lymphocytic leukaemia (CLL): a tool to investigate the role of specific antigen in CLL biology
- C67: Targeted Radiotherapy with an anti-CD66 monoclonal antibody prior to haematopoietic stem cell transplantation: therapy intensification without toxicity
- C68: Mechanism of connective tissue growth factor deregulation in paediatric pre-B acute lymphoblastic leukaemia
- C69: Genome-wide epigenetic analysis of childhood acute lymphoblastic leukaemia
- C70: Radiation Therapy with Type II Anti-CD20 monoclonal antibody initiates extracellular signal-regulated Kinase/Mitogen-Activated protein kinase–dependent cell death that overcomes resistance to apoptosis
- C71: Prophylaxis of neutropenic complications during CHOP-R chemotherapy using GCSF: a 3 year case-control study
